COMMUNIQUÉS West-GlobeNewswire

Nicox annonce la soumission d’une NDA pour NCX 470 en Chine par son partenaire Ocumension
10/08/2026
Communiqué de presse Nicox annonce la soumission d’une NDA pour NCX 470 en Chine par son partenaire Ocumension Ocumension a soumis une demande d’autorisation de mise sur le marché (NDA) auprès de la National Medical [...]
Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
10/08/2026
Press Release Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension Ocumension has submitted the New Drug Application (NDA) to the Chinese National Medical Products Administration (NMPA) for NCX 470 to [...]
Kylo Peptides Expands Research Catalog to 36 Compounds as Peptide Science Enters a Record Growth Cycle
10/08/2026
US research-peptide supplier scales its catalog against a market that analysts value between $47 billion and $141 billion, as peptides hold near 10% of new FDA drug approvals and GLP-1 use among American adults doubles [...]
AB Science annonce aujourd’hui le succès d’augmentations de capital d’un montant brut total de 14,2 millions d’euros
10/08/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE DE 14,2 MILLIONS D’EUROS, SOUSCRIT PRINCIPALEMENT PAR UN INVESTISSEUR DE LONG TERME LA TRESORERIE D’AB SCIENCE S’ELEVE A ENVIRON 23 MILLIONS D’EUROS [...]
AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million
10/08/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 14.2 MILLION PRIVATE PLACEMENT, PRIMARILY SUSBCRIBED BY LONG TERM INVESTOR AB SCIENCE CASH POSITION IS AROUND EUR 23 MILLION AFTER THIS PRIVATE [...]
Actually Sleeping Surpasses 211 Families Served With Personalized Baby and Toddler Sleep Coaching
09/08/2026
Founder Dr. Samantha Abramson pairs a pharmacy background with real-time sleep tracking and one-on-one coaching to help parents build routines that work for their household United States, Aug. 09, 2026 (GLOBE NEWSWIRE [...]
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
09/08/2026
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive [...]
AVITA Medical to Host Investor Webinar Briefing
10/08/2026
VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
10/08/2026
BOSTON, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kyungdong Pharmaceutical announced that it has successfully completed a cell line development campaign for a biosimilar antibody candidate, in collaboration with Asimov, the [...]
Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026
08/08/2026
Montreal, QC, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Tyros Biopharma, a privately held Canadian pharmaceutical company focused on women’s health, is pleased to announce its continued growth following the addition of four new [...]
Life Peptides Launches Company-Wide Transparency Initiative to Advance Research Peptide Quality and Buyer Education
08/08/2026
Cheyenne, Wyoming, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Life Peptides , a trusted supplier of high-purity laboratory research peptides, announces the launch of a company-wide transparency initiative designed to help [...]
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The PSP Trial Platform (PTP), a landmark clinical trial testing multiple drugs simultaneously in the search for effective PSP treatments, has enrolled its first participant. [...]
DirectMax Prescription Management Update Details Patient Support and Telehealth Access Through Direct Meds
07/08/2026
Direct Meds details DirectMax prescription management, provider communication, refill administration, patient support and telehealth access. Houston, TX, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The update brings DirectMax [...]
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
07/08/2026
MINNEAPOLIS, MN, US, Aug. 07, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), an emerging biomedical company delivering innovative medical devices and therapeutics for equines and companion [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
WESTLAKE VILLAGE, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
07/08/2026
Company awaiting comments from FDA by the end of August 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis. Workforce reduction of approximately 60% and program [...]
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
CAMBRIDGE, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
07/08/2026
LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46 th Annual Growth [...]

Pages